Wells Fargo’s Genesis Healthcare, Inc. GEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-405
Closed 7728
2020
Q4
$0 Sell
405
-95,943
-100% -$48.5K ﹤0.01% 7361
2020
Q3
$52K Sell
96,348
-10,933
-10% -$7.86K ﹤0.01% 5501
2020
Q2
$74K Sell
107,281
-46,460
-30% -$37.4K ﹤0.01% 5356
2020
Q1
$129K Buy
153,741
+15,674
+11% +$22.4K ﹤0.01% 4936
2019
Q4
$227K Buy
138,067
+110,051
+393% +$165K ﹤0.01% 4873
2019
Q3
$32K Sell
28,016
-864
-3% -$999 ﹤0.01% 5689
2019
Q2
$36K Sell
28,880
-6,751
-19% -$8.6K ﹤0.01% 5658
2019
Q1
$51K Buy
35,631
+4,135
+13% +$6.13K ﹤0.01% 5314
2018
Q4
$37K Buy
31,496
+161
+0.5% +$239 ﹤0.01% 5618
2018
Q3
$42K Sell
31,335
-1,681
-5% -$2.66K ﹤0.01% 5646
2018
Q2
$76K Sell
33,016
-192
-0.6% -$371 ﹤0.01% 5482
2018
Q1
$51K Sell
33,208
-126
-0.4% -$148 ﹤0.01% 5558
2017
Q4
$25K Sell
33,334
-54,671
-62% -$48.9K ﹤0.01% 5738
2017
Q3
$102K Buy
88,005
+42,676
+94% +$53.8K ﹤0.01% 5230
2017
Q2
$80K Sell
45,329
-94,722
-68% -$201K ﹤0.01% 5262
2017
Q1
$370K Sell
140,051
-84,830
-38% -$305K ﹤0.01% 4444
2016
Q4
$956K Buy
224,881
+194,180
+632% +$640K ﹤0.01% 3732
2016
Q3
$82K Buy
30,701
+18,915
+160% +$43.5K ﹤0.01% 5033
2016
Q2
$21K Sell
11,786
-3,973
-25% -$8.11K ﹤0.01% 5485
2016
Q1
$37K Buy
15,759
+3,786
+32% +$8.56K ﹤0.01% 5330
2015
Q4
$41K Sell
11,973
-1,590
-12% -$7.61K ﹤0.01% 5359
2015
Q3
$83K Buy
13,563
+1,442
+12% +$9.78K ﹤0.01% 5020
2015
Q2
$80K Sell
12,121
-30,715
-72% -$207K ﹤0.01% 5176
2015
Q1
$304K Buy
+42,836
New +$323K ﹤0.01% 4212

Other funds holding GEN

Wells Fargo's GEN Position: Q1 2021 in Review

Wells Fargo sold out of Genesis Healthcare, Inc. (GEN) in Q1 2021, closing a stake of 405 shares.

Wells Fargo first reported a position in GEN in Q1 2015 and held it in 24 quarters. The position peaked at $956K in Q4 2016. 8 funds tracked by Wall St. Rank hold GEN as of Q1 2021.

  • Wells Fargo reported no remaining Genesis Healthcare, Inc. position as of Q1 2021 after selling out during the quarter.
  • Wells Fargo sold 405 Genesis Healthcare, Inc. shares in Q1 2021.
  • Wells Fargo first reported a position in Genesis Healthcare, Inc. in Q1 2015 and held it in 24 quarters.
  • Wells Fargo's Genesis Healthcare, Inc. position peaked at $956K in Q4 2016.
  • 8 funds tracked by Wall St. Rank held Genesis Healthcare, Inc. as of Q1 2021.

Based on Wells Fargo's 13F filing for Q1 2021, filed 13 May 2021.